메뉴 건너뛰기




Volumn 877, Issue 29, 2009, Pages 3506-3514

Development and validation of a semi-automated assay for the highly sensitive quantification of Biolimus A9 in human whole blood using high-performance liquid chromatography-tandem mass spectrometry

Author keywords

Biolimus A9; Column switching; Drug eluting stents; Human whole blood; LC MS MS

Indexed keywords

AUTOSAMPLERS; CLINICAL TRIAL; COLUMN SWITCHING; DRUG-ELUTING STENTS; FREEZE-THAW CYCLES; HIGH SENSITIVITY; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; HIGHLY SENSITIVE; HUMAN PHARMACOKINETICS; INTERNAL STANDARDS; ION SUPPRESSION; LC-MS/MS; LOWER LIMIT OF DETECTIONS; LOWER LIMIT OF QUANTITATIONS; MATRIX INTERFERENCE; PERFORMANCE CHARACTERISTICS; PROTEIN PRECIPITATION; SEMI-AUTOMATED; STENT IMPLANTATION; SUSTAINED-RELEASE; WHOLE BLOOD;

EID: 72049086018     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.08.020     Document Type: Article
Times cited : (12)

References (21)
  • 11
    • 0003484310 scopus 로고    scopus 로고
    • accessed January 27th, 2009
    • Center for Drug Evaluation and Research (CDER), Guidance for Industry, Bioanalytical Method Validation, 2001, www.fda.gov/cder/guidance/4252fnl.htm (accessed January 27th, 2009).
    • (2001) Guidance for Industry, Bioanalytical Method Validation


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.